09688 再鼎醫藥
公司資料 - 股權變動
日期 股東名稱 披露原因 買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
16/07/2024Janus Henderson Group PLC11031(L)+4,081,270(L)71,492,500(L)7.18
16/07/2024The Capital Group Companies, Inc.1201(L)-8,058,780(L)59,334,790(L)5.96
09/07/2024JPMorgan Chase & Co.16021(L)+6,489,432(L)HKD 12.832(L)130,633,523(L)
16,256,110(S)
111,880,460(P)
13.11
1.63
11.23
01/07/2024杜瑩1201(L)-70,130(L)59,499,580(L)5.97
01/07/2024陳凱先1201(L)-77,500(L)607,780(L)0.06
29/06/2024杜瑩1316(L)179,700(L)59,569,710(L)5.98
26/06/2024杜瑩1316(L)588,000(L)59,809,100(L)6.01
26/06/2024杜瑩1201(L)-239,390(L)59,569,710(L)5.99
26/06/2024The Capital Group Companies, Inc.1201(L)-685,700(L)HKD 14.350(L)69,183,840(L)6.96
20/06/2024JPMorgan Chase & Co.16022(L)
1502(S)
-7,134,736(L)
-1,932,163(S)
HKD 13.946(L)124,665,436(L)
18,742,607(S)
102,364,135(P)
12.56
1.88
10.31
18/06/2024Gaynor Richard Brian1113(L)+212,530(L)490,680(L)0.04
18/06/2024Moulder Jr Leon Oliver1113(L)+212,530(L)617,710(L)0.06
18/06/2024Vounatsos Michel Pericles1113(L)+212,530(L)395,850(L)0.03
18/06/2024陳凱先1113(L)+212,530(L)685,280(L)0.06
18/06/2024Diekman John David1113(L)+212,530(L)889,380(L)0.08
18/06/2024Morrison Scott William1113(L)+212,530(L)475,010(L)0.04
18/06/2024Lis William David1113(L)+212,530(L)634,860(L)0.06
18/06/2024Wirth Peter Karl1113(L)+212,530(L)3,829,190(L)0.38
13/06/2024Janus Henderson Group PLC11031(L)+1,733,240(L)60,199,230(L)6.07
07/06/2024JPMorgan Chase & Co.1104(L)+2,112,072(L)HKD 14.996(L)130,653,442(L)
25,769,429(S)
102,707,787(P)
13.16
2.59
10.35
04/06/2024JPMorgan Chase & Co.1201(L)-7,983,967(L)HKD 15.469(L)126,673,479(L)
23,502,176(S)
100,061,276(P)
12.76
2.36
10.08
31/05/2024Wellington Management Group LLP1101(L)+15,488,617(L)HKD 14.544(L)107,384,700(L)
6,345(S)
10.82
0.00
23/05/2024Wellington Management Group LLP1101(L)+1,012,743(L)USD 18.922(L)90,231,657(L)
6,342(S)
9.10
0.00
22/05/2024Wellington Management Group LLP1201(L)-126,385(L)USD 20.321(L)89,218,914(L)
6,340(S)
8.99
0.00
16/05/2024JPMorgan Chase & Co.1201(L)-4,353,109(L)HKD 15.820(L)127,518,115(L)
29,977,932(S)
92,251,866(P)
12.85
3.02
9.29
14/05/2024JPMorgan Chase & Co.1201(L)-18,578,241(L)HKD 16.822(L)131,871,224(L)
31,325,568(S)
91,782,695(P)
13.29
3.15
9.25
13/05/2024UBS Group AG1704(L)-1,913,187(L)47,974,048(L)
14,461,881(S)
4.84
1.46
13/05/2024JPMorgan Chase & Co.1201(L)-24,861,249(L)HKD 16.743(L)150,449,465(L)
31,153,414(S)
91,491,753(P)
15.16
3.14
9.22
10/05/2024JPMorgan Chase & Co.1101(L)+19,513,089(L)HKD 15.906(L)175,310,714(L)
36,076,150(S)
91,506,693(P)
17.67
3.63
9.22
09/05/2024Wellington Management Group LLP1101(L)+4,308,618(L)USD 20.472(L)90,353,596(L)
7,211(S)
9.11
0.00
09/05/2024JPMorgan Chase & Co.1101(L)
1503(S)
+23,001,241(L)
-5,857,886(S)
HKD 15.654(L)155,797,625(L)
37,915,202(S)
91,484,685(P)
15.70
3.82
9.22
09/05/2024UBS Group AG1004(L)+2,053,000(L)51,253,615(L)
15,011,831(S)
5.17
1.51
07/05/2024UBS Group AG1704(L)-936,000(L)49,281,226(L)
13,461,711(S)
4.97
1.36
06/05/2024UBS Group AG1013(L)+534,820(L)49,916,421(L)
14,273,791(S)
5.41
1.44
30/04/2024JPMorgan Chase & Co.1502(S)-1,093,238(S)135,910,128(L)
49,294,503(S)
93,590,733(P)
13.69
4.96
9.43
26/04/2024JPMorgan Chase & Co.1402(S)+1,556,138(S)134,255,300(L)
50,250,533(S)
93,250,055(P)
13.53
5.06
9.39
25/04/2024The Capital Group Companies, Inc.1201(L)-1,100,110(L)78,592,480(L)7.92
25/04/2024JPMorgan Chase & Co.1503(S)-1,409,641(S)132,904,855(L)
48,694,395(S)
92,994,945(P)
13.39
4.90
9.37
23/04/2024JPMorgan Chase & Co.16021(L)+7,775,091(L)HKD 11.820(L)135,360,441(L)
52,474,567(S)
93,548,251(P)
13.64
5.28
9.42
22/04/2024UBS Group AG1704(L)-1,894,000(L)48,269,057(L)
13,585,968(S)
4.87
1.37
  1    2    3    4    5    6    7   8    9    10  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.